抗体药物缀合物:技术和全球市场
Report Highlights
The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.
Report Includes
- An overview of the global market for antibody drug conjugates as a part of the pharmaceutical industry that is looking for innovative technologies.
- Analyses of global market trends, with data from 2014, 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- 检查主要市场驱动因素和挑战。
- Insight into regulatory hurdles and how to meet them, as well as discussion of the drugs (and the companies behind them) that have received approval.
报告范围
抗体药物结合物主要用于治疗癌症,并且比许多其他癌症疗法更安全,更有效。该报告着重于全球抗体药物共轭产品市场,并提供了更新的综述,包括其在生物医学各个领域的基本设计和应用。该报告涵盖了乳腺癌,淋巴瘤和其他癌症的三个主要领域,包括急性髓样白血病。这项研究的范围包括当前的ADC市场。该报告还讨论了监管方面,当前和发展的技术,市场预测和市场份额。该报告还讨论了对临床试验,创新和机会以及ADC市场最新趋势的分析。
报告中还包括对领导抗体药物共轭产品市场的公司的专利和配置文件进行分析。西雅图Genetics Inc.,Takeda Pharmaceuticals Co. Ltd.和Genentech Inc.是目前ADC市场的主要参与者。
通过统计分析证实了全球和区域市场的销售数据,并预测价值,销售在地理上分解为北美,欧洲,亚太地区和新兴市场。从商业角度和研发(R&D)角度讨论了ADC在各种类型癌症中的应用。
该报告仅涵盖抗体药物结合物,其中抗体与小分子细胞毒素(有效载荷)通过接头结合。ADC是一种抗体结合物的形式。其他形式的抗体结合物,例如与抗体结合的放射性同位素,超出了本报告的范围。该研究还不涵盖不包含接头和细胞毒性剂的mAB,因此不构成ADC。
分析师证书
Shalini Shahani Dewan专注于药物和生物技术,自2002年以来一直是BCC研究贡献者,既是分析师又是项目经理。乐动体育-西甲2019赞助商她探索了广泛的主题和公司,包括在约翰逊和约翰逊进行市场监视。她拥有药学学士学位和药物化学硕士学位。她居住在湾区。
Report Highlights
ADC药物的全球市场在2012年达到1.79亿美元,2013年为3.96亿美元。2018年该市场应达到28亿美元,复合年增长率(CAGR)为48.1%。
Report Includes
- An overview of the global market for ADCs as a part of the pharmaceutical industry that is looking for innovative technologies.
- Analyses of global market trends, with data from 2012, 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- 检查主要市场驱动因素和挑战。
- Insight into regulatory hurdles and how to meet them, as well as discussion of the drugs (and the companies behind them) that have received approval.